TrialClinical and experimental nephrology2020

A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients.

Tatsuo Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.